Hypertension
From the Journals
Home blood pressure testing better than at clinics: Study
Individual measures of blood pressure are not as accurate as taking multiple readings over a day and averaging them.
Conference Coverage
Early menopause, early dementia risk, study suggests
Early menopause is linked to an increased risk of presenile dementia before age 65 years in a large study, suggesting the need for close...
From the Journals
One-third of psoriatic arthritis patients could have metabolic syndrome, data analysis finds
The results highlight the need for proper assessment of body weight and cardiovascular risk factors in patients with PsA at the onset of disease...
From the Journals
ARBs and cancer risk: New meta-analysis raises questions again
The trial-level analysis suggests a dose-response relationship between exposure to angiotensin receptor blockers and the risk for cancer.
Conference Coverage
‘Striking’ differences in BP when wrong cuff size is used
A new trial bolsters the case for avoiding a one-cuff-size-fits-all approach to measuring blood pressure and for improving patient access to a...
From the Journals
How Lp(a) can help improve ASCVD risk assessment
Calcium scores and lipoprotein(a) levels predict 10-year risk independent of each other, and together could swing shared decision-making about...
Commentary
What is the healthiest salt for you?
The key to which salt is healthiest depends on the person. Our bodies need some sodium to function, just not in large amounts.
From the Journals
Oil spill cleanup work tied to hypertension risk years later
Workers who had the most exposure to hydrocarbons during the Deepwater Horizon oil spill disaster in 2010 had a higher risk of having a...
From the Journals
More than half of U.S. women enter pregnancy at higher CVD risk
A minority of women in the United States enter pregnancy in favorable cardiovascular health, new research suggests.
From the Journals
AHA targets ‘low-value’ heart care in new scientific statement
Low-value cardiovascular care providing little or no benefit is common, potentially harmful, and costly, and it will take key stakeholders to...
Latest News
Spironolactone not linked to increased cancer risk in systematic review and meta-analysis
The data are “reassuring,” the authors reported.